▶ 調査レポート

抗新生物剤のアメリカ市場

• 英文タイトル:United States Anti-Neoplastic Agents Market Report 2017
• レポートコード:A0502206369
• 出版社/出版日:QYResearch / 2017年4月19日
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:バイオ・医療・製薬
• 販売価格(消費税別)
  Single User License¥418,000 (USD3,800)▷ お問い合わせ
  Enterprise License¥836,000 (USD7,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、アメリカの抗新生物剤市場について調査・分析し、抗新生物剤のアメリカ市場概観、抗新生物剤の種類別市場分析、用途別市場分析、抗新生物剤のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・抗新生物剤のアメリカ市場概観
・抗新生物剤の種類別市場規模
・抗新生物剤の用途別市場規模
・抗新生物剤のアメリカ市場規模
・抗新生物剤のアメリカ市場予測
・抗新生物剤の製造メーカー分析
・抗新生物剤のメーカー別生産量
・抗新生物剤のメーカー別市場シェア
・抗新生物剤の価格動向・価格分析
・抗新生物剤の販売(売上高)動向
・抗新生物剤の貿易(輸出・輸入)動向
・抗新生物剤の産業チェーン分析
・抗新生物剤のマーケティング戦略分析
・抗新生物剤の販売業者(代理店)リスト
・抗新生物剤の市場環境分析
...

In this report, the United States Anti-Neoplastic Agents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anti-Neoplastic Agents in these regions, from 2012 to 2022 (forecast).

United States Anti-Neoplastic Agents market competition by top manufacturers/players, with Anti-Neoplastic Agents sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Baxter Healthcare
Boehringer Ingelheim
Aspen Global
Bayer AG
Teva pharmaceutical Industries
Johnson & Johnson
Merc & Co.
Pfize
Accord Healthcare
Genentech
Lundbeck
AbbVie

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-Neoplastic Agents for each application, including
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

レポート目次

Table of Contents

United States Anti-Neoplastic Agents Market Report 2017
1 Anti-Neoplastic Agents Overview
1.1 Product Overview and Scope of Anti-Neoplastic Agents
1.2 Classification of Anti-Neoplastic Agents by Product Category
1.2.1 United States Anti-Neoplastic Agents Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Anti-Neoplastic Agents Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Chemotherapeutic Agents
1.2.4 Biological/Immunotherapeutic Agents
1.2.5 Personalized Medicine
1.3 United States Anti-Neoplastic Agents Market by Application/End Users
1.3.1 United States Anti-Neoplastic Agents Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Rehabilitation Centers
1.3.5 Ambulatory Surgical Centers
1.4 United States Anti-Neoplastic Agents Market by Region
1.4.1 United States Anti-Neoplastic Agents Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Anti-Neoplastic Agents Status and Prospect (2012-2022)
1.4.3 Southwest Anti-Neoplastic Agents Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Anti-Neoplastic Agents Status and Prospect (2012-2022)
1.4.5 New England Anti-Neoplastic Agents Status and Prospect (2012-2022)
1.4.6 The South Anti-Neoplastic Agents Status and Prospect (2012-2022)
1.4.7 The Midwest Anti-Neoplastic Agents Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anti-Neoplastic Agents (2012-2022)
1.5.1 United States Anti-Neoplastic Agents Sales and Growth Rate (2012-2022)
1.5.2 United States Anti-Neoplastic Agents Revenue and Growth Rate (2012-2022)

2 United States Anti-Neoplastic Agents Market Competition by Players/Suppliers
2.1 United States Anti-Neoplastic Agents Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anti-Neoplastic Agents Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anti-Neoplastic Agents Average Price by Players/Suppliers (2012-2017)
2.4 United States Anti-Neoplastic Agents Market Competitive Situation and Trends
2.4.1 United States Anti-Neoplastic Agents Market Concentration Rate
2.4.2 United States Anti-Neoplastic Agents Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anti-Neoplastic Agents Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anti-Neoplastic Agents Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Anti-Neoplastic Agents Sales and Market Share by Region (2012-2017)
3.2 United States Anti-Neoplastic Agents Revenue and Market Share by Region (2012-2017)
3.3 United States Anti-Neoplastic Agents Price by Region (2012-2017)

4 United States Anti-Neoplastic Agents Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Anti-Neoplastic Agents Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anti-Neoplastic Agents Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Neoplastic Agents Price by Type (2012-2017)
4.4 United States Anti-Neoplastic Agents Sales Growth Rate by Type (2012-2017)

5 United States Anti-Neoplastic Agents Sales (Volume) by Application (2012-2017)
5.1 United States Anti-Neoplastic Agents Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Neoplastic Agents Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Anti-Neoplastic Agents Players/Suppliers Profiles and Sales Data
6.1 Hoffmann-La Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Hoffmann-La Roche Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Amgen
6.2.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb
6.3.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bristol-Myers Squibb Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Baxter Healthcare
6.4.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Baxter Healthcare Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Boehringer Ingelheim
6.5.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Boehringer Ingelheim Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Aspen Global
6.6.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Aspen Global Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Bayer AG
6.7.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Bayer AG Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Teva pharmaceutical Industries
6.8.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Teva pharmaceutical Industries Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Johnson & Johnson
6.9.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Johnson & Johnson Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Merc & Co.
6.10.2 Anti-Neoplastic Agents Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Merc & Co. Anti-Neoplastic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Pfize
6.12 Accord Healthcare
6.13 Genentech
6.14 Lundbeck
6.15 AbbVie

7 Anti-Neoplastic Agents Manufacturing Cost Analysis
7.1 Anti-Neoplastic Agents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Neoplastic Agents

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Neoplastic Agents Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Neoplastic Agents Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Anti-Neoplastic Agents Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Anti-Neoplastic Agents Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anti-Neoplastic Agents Sales Volume Forecast by Type (2017-2022)
11.3 United States Anti-Neoplastic Agents Sales Volume Forecast by Application (2017-2022)
11.4 United States Anti-Neoplastic Agents Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Anti-Neoplastic Agents
Figure United States Anti-Neoplastic Agents Market Size (K Pcs) by Type (2012-2022)
Figure United States Anti-Neoplastic Agents Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemotherapeutic Agents Product Picture
Figure Biological/Immunotherapeutic Agents Product Picture
Figure Personalized Medicine Product Picture
Figure United States Anti-Neoplastic Agents Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Anti-Neoplastic Agents by Application in 2016
Figure Hospitals Examples
Figure Clinics Examples
Figure Cancer Rehabilitation Centers Examples
Figure Ambulatory Surgical Centers Examples
Figure United States Anti-Neoplastic Agents Market Size (Million USD) by Region (2012-2022)
Figure The West Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Neoplastic Agents Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Neoplastic Agents Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Anti-Neoplastic Agents Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Anti-Neoplastic Agents Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Neoplastic Agents Sales Share by Players/Suppliers
Figure 2017 United States Anti-Neoplastic Agents Sales Share by Players/Suppliers
Figure United States Anti-Neoplastic Agents Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anti-Neoplastic Agents Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anti-Neoplastic Agents Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Neoplastic Agents Revenue Share by Players/Suppliers
Figure 2017 United States Anti-Neoplastic Agents Revenue Share by Players/Suppliers
Table United States Market Anti-Neoplastic Agents Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Anti-Neoplastic Agents Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Anti-Neoplastic Agents Market Share of Top 3 Players/Suppliers
Figure United States Anti-Neoplastic Agents Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anti-Neoplastic Agents Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anti-Neoplastic Agents Product Category
Table United States Anti-Neoplastic Agents Sales (K Pcs) by Region (2012-2017)
Table United States Anti-Neoplastic Agents Sales Share by Region (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Share by Region (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Market Share by Region in 2016
Table United States Anti-Neoplastic Agents Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anti-Neoplastic Agents Revenue Share by Region (2012-2017)
Figure United States Anti-Neoplastic Agents Revenue Market Share by Region (2012-2017)
Figure United States Anti-Neoplastic Agents Revenue Market Share by Region in 2016
Table United States Anti-Neoplastic Agents Price (USD/Pcs) by Region (2012-2017)
Table United States Anti-Neoplastic Agents Sales (K Pcs) by Type (2012-2017)
Table United States Anti-Neoplastic Agents Sales Share by Type (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Share by Type (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Market Share by Type in 2016
Table United States Anti-Neoplastic Agents Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anti-Neoplastic Agents Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Neoplastic Agents by Type (2012-2017)
Figure Revenue Market Share of Anti-Neoplastic Agents by Type in 2016
Table United States Anti-Neoplastic Agents Price (USD/Pcs) by Types (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Growth Rate by Type (2012-2017)
Table United States Anti-Neoplastic Agents Sales (K Pcs) by Application (2012-2017)
Table United States Anti-Neoplastic Agents Sales Market Share by Application (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Market Share by Application (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Market Share by Application in 2016
Table United States Anti-Neoplastic Agents Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Neoplastic Agents Sales Growth Rate by Application (2012-2017)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Hoffmann-La Roche Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Hoffmann-La Roche Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Amgen Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Amgen Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Baxter Healthcare Basic Information List
Table Baxter Healthcare Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Baxter Healthcare Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Baxter Healthcare Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Baxter Healthcare Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Aspen Global Basic Information List
Table Aspen Global Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aspen Global Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Aspen Global Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Aspen Global Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Bayer AG Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Bayer AG Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Teva pharmaceutical Industries Basic Information List
Table Teva pharmaceutical Industries Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva pharmaceutical Industries Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Teva pharmaceutical Industries Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Teva pharmaceutical Industries Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Merc & Co. Basic Information List
Table Merc & Co. Anti-Neoplastic Agents Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merc & Co. Anti-Neoplastic Agents Sales Growth Rate (2012-2017)
Figure Merc & Co. Anti-Neoplastic Agents Sales Market Share in United States (2012-2017)
Figure Merc & Co. Anti-Neoplastic Agents Revenue Market Share in United States (2012-2017)
Table Pfize Basic Information List
Table Accord Healthcare Basic Information List
Table Genentech Basic Information List
Table Lundbeck Basic Information List
Table AbbVie Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Neoplastic Agents
Figure Manufacturing Process Analysis of Anti-Neoplastic Agents
Figure Anti-Neoplastic Agents Industrial Chain Analysis
Table Raw Materials Sources of Anti-Neoplastic Agents Major Players/Suppliers in 2016
Table Major Buyers of Anti-Neoplastic Agents
Table Distributors/Traders List
Figure United States Anti-Neoplastic Agents Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Neoplastic Agents Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Neoplastic Agents Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Anti-Neoplastic Agents Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anti-Neoplastic Agents Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anti-Neoplastic Agents Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Anti-Neoplastic Agents Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anti-Neoplastic Agents Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anti-Neoplastic Agents Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Anti-Neoplastic Agents Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Anti-Neoplastic Agents Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Neoplastic Agents Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Neoplastic Agents Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources




• 英文レポート名:United States Anti-Neoplastic Agents Market Report 2017
• 日本語訳:抗新生物剤のアメリカ市場
• レポートコード:A0502206369お問い合わせ(見積依頼・ご注文・質問)